[25-005692] immunology center requires service contract in order to maintain facs fortessa x-20 sorp. Facs fortessa x-20 sorp is used as in vitro diagnostic device for identification and enumeration…
Ended Awarded Last action
- Contract number
- 75N92025F00050
- Awardee
-
Becton, Dickinson And Company UEI MM5ZHL8SRFY5 Part of Becton, Dickinson And Co
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $15,050
Award facts
- Contract value 100% obligated
- $15,050.34 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- San Jose, CA 95131, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$15,050 | |
| Original award | $30,101 |
About this award
This is a firm fixed-price delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for maintenance and repair services on a BD FACSFortessa X-20 SORP flow cytometry instrument. The contract has a ceiling value of $15,050.34 and a period of performance ending on September 28, 2025. The FACSFortessa X-20 SORP is an in vitro diagnostic device used for identifying and enumerating lymphocyte subsets in mouse and human cells. This contract does not utilize a small business set-aside. BD is a large, established medical technology manufacturer that has a significant portfolio of federal contract and grant awards, primarily focused on providing specialized flow cytometry instruments, related consumables, and comprehensive maintenance and technical support services to government research and healthcare institutions.
Description
[25-005692] immunology center requires service contract in order to maintain facs fortessa x-20 sorp. Facs fortessa x-20 sorp is used as in vitro diagnostic device for identification and enumeration of lymphocyte subsets in mouse and human cells. To
Quick answers
Who was awarded contract 75N92025F00050?
75N92025F00050 was awarded to Becton, Dickinson And Company by National Heart Lung and Blood Institute (National Institutes of Health) on March 1, 2025.
How much is contract 75N92025F00050 worth?
The government has obligated $15,050 on 75N92025F00050.
Is contract 75N92025F00050 an order under another contract?
Yes. 75N92025F00050 is a delivery order under GS07F195DA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N92025F00050 competed?
The extent of competition for 75N92025F00050 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award